A Cross-species Personalized Medicine Pipeline Identifies the CRM1 Export Pathway as a Potentially Novel Treatment for Osteosarcoma

OrthoMedia ◽  
2021 ◽  
Author(s):  
Eirini Konstantina Tafanidou ◽  
Despoina Gkentzi

: Since the emergence of SARS-CoV-2 in late December 2019, scientists have been racing against time to effectively develop a vaccine. As the techniques of personalized medicine are becoming more understood and approachable for mankind, vaccinations using such technologies could advance the treatment of all patients taking into consideration their genetic and biochemical background. As such, we anticipate that patients will be treated more effectively and potentially have less symptoms and side effects. This perspective is aiming to raise awareness of the oncoming novel treatment of diseases especially during the coronavirus pandemic.


2005 ◽  
Vol 47 (09) ◽  
pp. 636 ◽  
Author(s):  
Edward Dabrowski ◽  
Sarah A Smathers ◽  
Curt S Ralstrom ◽  
Michael A Nigro ◽  
Jimmie P Leleszi

2009 ◽  
Vol 47 (05) ◽  
Author(s):  
Á Pap ◽  
M Burai ◽  
Á Tarpay

2015 ◽  
Vol 63 (S 03) ◽  
Author(s):  
A. Arndt ◽  
M. Beerens ◽  
H. Kramer ◽  
S. Klaassen ◽  
C. MacRae

2016 ◽  
Vol 21 (09) ◽  
pp. 52-52

Die Digitalisierung und das Gesundheitswesen sind Partner, die es in Zukunft gemeinsam noch sehr weit bringen können – das ist die Botschaft des SAP Personalized Medicine Forum, das am 6. und 7. Juli in Bonn stattfand.


Sign in / Sign up

Export Citation Format

Share Document